BioAge Labs (BIOA) announced that the company has made the decision to discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag as monotherapy and in combination ...
SHANGHAI, China and ST. HELIER, Jersey, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, and Novocure ...
SHANGHAI & CAMBRIDGE, Mass. & BAAR, Switzerland--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Novocure (NASDAQ: NVCR) announced that results from the Phase 3 PANOVA-3 trial of Tumor ...
- Zai Lab (ZLAB) will highlight potential of ZL-1310 as a promising, best-in-class Delta-like ligand (DLL3-targeted) ADC for patients with extensive-stage small cell lung cancer (ES-SCLC) - Investor ...
Durango School District 9-R is celebrating the completion of phase 2 of its SOIL Outdoor Learning Lab and community garden at Riverview Elementary School in northeast Durango. Durango School District ...
It will focus on advanced technologies for aftermarket services, amongst others. The Agency for Science, Technology and Research (A*STAR), Rolls-Royce, and Singapore Aero Engine Services Private ...
Zai Lab (ZLAB) presented promising phase 1 results of ZL-1310, its DLL3 antibody drug conjugate (‘ADC’) candidate, in patients with extensive-stage small cell lung cancer (‘ES-SCLC’) this week. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results